Windlas Biotech Q3 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
947.95
-44.60 (-4.49%)
-44.60 (-4.49%)Volume9.27 K
Updated: Fri 9 Oct, 2026 | 15:57:33
NSE
949.20-42.40 (-4.28%)
-42.40 (-4.28%)Volume1.29 L
Updated: Fri 9 Oct, 2026 | 15:31:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Windlas Biotech Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 216.42 | 170.45 | 7.44% | 145.27 | 22.05% |
| Depreciation/ Amortization | 7.70 | 6.50 | 1.34% | 3.39 | 10.95% |
| Operating Income | 16.68 | 16.55 | -20.43% | 16.95 | -5.73% |
| Net Income | 15.00 | 15.66 | -15.72% | 15.10 | -3.69% |
| Other Operating Expenses Total | 23.18 | 16.56 | 13.36% | 17.50 | 33.31% |
| Net Income Before Taxes | 19.97 | 20.29 | -15.33% | 19.81 | -1.80% |
| Total Revenue | 233.10 | 187.00 | 4.81% | 162.21 | 19.53% |
| Selling/ General/ Admin Expenses Total | 42.05 | 30.97 | 15.37% | 22.73 | 30.70% |
| Diluted Normalized EPS | 7.05 | 7.43 | -16.07% | 7.26 | -4.47% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.